Stefan R A Konings
Overview
Explore the profile of Stefan R A Konings including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
14
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Poppe A, Tiles-Sar N, Konings S, Habtewold T, Bruggeman R, Alizadeh B, et al.
Soc Psychiatry Psychiatr Epidemiol
. 2024 Jan;
59(7):1243-1254.
PMID: 38189942
Purpose: Living independently, as opposed to in sheltered housing or with caregivers, is an important aim in the recovery of individuals with psychosis, but the transition to independence can be...
2.
Konings S, Mierau J, Visser E, Bruggeman R, Feenstra T
Acta Psychiatr Scand
. 2023 Sep;
148(4):338-346.
PMID: 37697672
Background: Mental disorders are burdensome and are associated with increased mortality. Mortality has been researched for various mental disorders, especially in countries with national registries, including the Nordic countries. Yet,...
3.
Tiozzo G, Louwsma T, Konings S, Vondeling G, Perez Gomez J, Postma M, et al.
Expert Rev Vaccines
. 2023 May;
22(1):410-418.
PMID: 37132424
Background: Evidence-based reassurances addressing vaccine-related concerns are crucial to promoting primary vaccination, completion of the primary series, and booster vaccination. By summarizing and comparing the reactogenicity of COVID-19 vaccines authorized...
4.
Al Khayat M, Armstrong N, Howick J, OMeara S, Posadzki P, Ryder S, et al.
Pharmacoeconomics
. 2023 Feb;
41(4):353-361.
PMID: 36757608
The National Institute for Health and Care Excellence (NICE) invited the manufacturer (Roche) of pralsetinib (Gavreto), as part of the single technology appraisal (STA) process, to submit evidence for the...
5.
Emamipour S, Pagano E, Di Cuonzo D, Konings S, van der Heijden A, Elders P, et al.
Acta Diabetol
. 2022 Apr;
59(7):949-957.
PMID: 35445871
Aims: Valid health economic models are essential to inform the adoption and reimbursement of therapies for diabetes mellitus. Often existing health economic models are applied in other countries and settings...
6.
Tuvdendorj A, Konings S, Purevdorj B, Buskens E, Feenstra T
Nicotine Tob Res
. 2021 Sep;
24(2):233-240.
PMID: 34498055
Background/objectives: Smoking is the leading risk factor for many chronic diseases. The quantitative analysis of potential health gains from reduced smoking is important for establishing priorities in Mongolia's health policy....
7.
Konings S, Bruggeman R, Visser E, Schoevers R, Mierau J, Feenstra T
Soc Sci Med
. 2020 Dec;
270:113507.
PMID: 33383484
Background: Schizophrenia Spectrum Disorder (SSD) is characterized by its chronic, episodic nature. The clear definition of such episodes is essential for various clinical and research purposes. Most current definitions of...
8.
Pagano E, Konings S, Di Cuonzo D, Rosato R, Bruno G, van der Heijden A, et al.
Diabetes Obes Metab
. 2020 Dec;
23(5):1084-1091.
PMID: 33377255
Aim: To externally validate the UK Prospective Diabetes Study Outcomes Model version 2 (UKPDS-OM2) by comparing the predicted and observed outcomes in two European population-based cohorts of people with type...